INS and metabolic dysfunction-associated steatotic liver disease: As for metabolism disorders, dysregulated glucose metabolism and insulin resistance stimulate insulin secretion, increasing hepatic triglyceride synthesis, which elevates plasma triglycerides and promotes NAFLD progression (89).